Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Mayo Clinic
- Study ID
- NCT04567771
- Status
- Recruiting
Conditions
- Cervical Carcinoma
- Endometrial Carcinoma
- Endometriosis
- Pelvic Inflammatory Disease
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Quality-of-Life Assessment — OTHERComplete quality of life questionnaires
- Questionnaire Administration — OTHERComplete adverse event assessments
- Radiation Therapy — RADIATIONUndergo proton or intensity modulated radiation therapy
Study Details
This early phase I trial compares the side effects between patients treated with proton radiation therapy versus intensity modulated radiation therapy after surgery for the treatment of endometrial or cervical cancer. Radiation therapy uses high energy protons or x-rays to kill tumor cells and shrink tumors. Using quality of life questionnaires and adverse event assessments may help doctors learn whether proton radiation therapy is associated with lower acute gastrointestinal toxicities at the end of treatment compared to intensity modulated radiation therapy in patients with endometrial or cervical cancer.
Key Dates
- Start date
- Dec 4, 2020
- Status verified
- Apr 2026
- Primary completion
- Oct 15, 2028
- Completion
- Oct 15, 2028
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment (radiation therapy, questionnaires)Patients undergo standard of care proton or intensity modulated radiation therapy. Patients also complete quality of life questionnaires and adverse event assessments over 10-15 minutes each at baseline, at the end of radiation therapy, and at 1 month, 1 year, and 3 years post-radiation therapy.
Primary Outcome Measure
Change in Expanded Prostate Cancer Index Composite (EPIC) Bowel score [ Time Frame: Baseline up to 3 years post-radiation therapy (RT) ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Arizona | Scottsdale | Arizona | 85259 | Sujay A. Vora, M.D. (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic in Florida | Jacksonville | Florida | 32224-9980 | - |
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Allison E. Garda, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Scottsdale, AZ
Related Studies
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPHASE1/PHASE2 · Recruiting · Children's Oncology Group · Birmingham, Alabama
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruiting · Guardant Health, Inc. · Birmingham, Alabama
- A Beta-only IL-2 ImmunoTherapY StudyPHASE1/PHASE2 · Recruiting · Medicenna Therapeutics, Inc. · San Diego, California
- Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)Recruiting · Aspira Women's Health · Chandler, Arizona